Point of Care Diagnostics 2016 Agenda

Registration

A Short History of Point of Care Testing: Using What We Know to Get to Precision Medicine
Elizabeth Wagar, Professor, The University of Texas MD Anderson Cancer Center, United States of America

Point-of-care testing has transitioned from early easy-to-understand concepts to a more complicated paradigm. What has influenced this transition? A number of factors will be discussed including regulatory factors, the evolution of point-of-care technology, healthcare economics, and the development of cutting-edge personalized care. These factors challenge the point-of-care market. Discussion of these factors will be provided to assist in directing technology toward point-of-care utilization.

Antibody Microarrays for Point of Care Detection from a Single Drop of Blood
Ashutosh Chilkoti, Director, Duke University, United States of America

I will discuss a point-of-care diagnostic, the D4 Assay that we have developed, in which all reagents are printed and stored on a “non-fouling”protein and cell resistant polymer brush. 

Coffee and Networking in Exhibition Hall

Bioanalytical surfaces for PoC applications
Thomas Brandstetter, Group Leader, University of Freiburg, Germany

Point of Care diagnostics (PoCD) require rapid, simple, easy to handle and low-cost bioanalytical approaches. Bioanalytical surfaces play a key role for achieving diagnostic requirements. Here, we review the state of the art of bioanalytical surfaces for PoCD.

Paper Microfluidic Sensors for Point-of-care Diagnostic Applications in Low-resource Settings
Elain Fu, Professor, Oregon State University, United States of America

This presentation will highlight the development of paper microfluidic tests for infectious disease diagnosis and therapy monitoring in low-resource settings.

Small Form Factor CMOS Based Sensors For Fast Detection Of Microorganisms And Bio Markers
Valerio Pruneri, Group Leader, ICFO, Barcelona, Spain

Lunch & Networking in Exhibition Hall

Technology Spotlight:
Introducing micropoc®: High quality POC Results on Reader-less, Fully Disposable Systems Designed for Low Cost Manufacture
Simon Forster, General Manager, Carclo Diagnostic Solutions

An overview of the exciting development of a group of unique POCT platforms that utilise novel microfluidics design, material science, precision manufacturing, micro-electronics and biochemistry, to provide high quality results on reader-less, fully disposable systems for a wide range of applications.

Particular Points of Care for External Quality Assessment
Timothy Woods, Deputy Director, UK NEQAS for Blood Coagulation, United Kingdom

Micro-Technologies as Enablers for Point-of-Care Applications
Daniel Caminada, Section Head Microdiagnostics, Swiss Center for Electronics and Microtechnology, Switzerland

Next generation Point-of-Care devices are enabled by Micro-Technologies. CSEM SA is an applied research and technology organization with technology transfer to the industry in mind. Relevant in-house technology platforms for the diagnostic industry as well as the value of collaborations are highlighted.

Coffee and Networking in Exhibition Hall

The Accuracy of Point-of-care Glucose Testing and Its Impact on the Management of Critically Ill Patients
Kathie Hermayer, Professor of Medcine, Medical University of South Carolina, United States of America
Yusheng Zhu, Professor, Medical University of South Carolina, United States of America

This talk will recognize the pathophysiological changes of critically ill patients, review the limitations of the current point-of-care (POC) glucose meters and discuss the new FDA guidelines and quality requirement for future POC glucose meters.

Drinks Reception

SACA Chip for Rapid Circulating Tumor Cells Diagnostics
Fan-Gang Tseng, Distinguished Professor, National Tsing-Hua University, Taiwan

This talk will introduce a novel micro fluidic platform which can isolate CTCs from the real blood sample in 30 minutes by using Self Assembled Cell Array (SACA) technology. Clinical breast cancer and colon cancer samples were verified with high consistency to the patient prognostics.

New Approaches for Point-of-care Tuberculosis Testing for Low Resource Settings in the Context of the TB/Diabetes Comorbidity
Bernhard Weigl, Director, Center for In-Vitro Diagnostics, Intellectual Ventures/Global Good-Bill Gates Venture Fund, United States of America

Coffee and Networking in Exhibition Hall

Monitoring Infections using Electrochemical Sensors that Detect Bacterial Metabolites
Edgar Goluch, Assistant Professor, Northeastern University, United States of America

This presentation will discuss the application of electrochemical sensors for detecting and monitoring the status of infections in bodily fluids based on detection of metabolites excreted by pathogens.

The Programmable Bio-Nano-Chip: A Platform to Digitize Biology Using Sensor Ensembles That Learn
John McDevitt, Professor, Rice University, United States of America

Lunch & Networking in Exhibition Hall

Centrifugal Microfluidic Platform for Universal Sample Preparation For Clinical Applications
Teodor Veres, Section Head, Bioanalytical Micro-Nano Devices, Life Sciences Division, National Research Council of Canada & McGill University, Canada

Point of care Cellular and Molecular Diagnostics at Resource Limited Setting
Aman Russom, Assistant Professor, KTH Royal Institute of Technology, Sweden

There is a growing demand for simple and reliable point-of-care (POC) diagnostics for use in resource-limited settings. Here, we describe how low-cost optical drives can, with minor modifications, be turned into POC diagnostic platforms for cellular and molecular diagnostics.

Coffee and Networking in Exhibition Hall

Clinical User Requirements For Point Of Care Testing Technology
Paul Collinson, Consultant Chemical Pathologist, St Georges University Hospitals NHS Foundation Trust, United Kingdom

The key user requirements for clinically useful point of care testing can be summarised as: appropriate analytical performance; ease of use; relevant testing panels; connectivity and cost effectiveness when incorporated into appropriate workflow process redesign.

Paper Microfluidics For The Diagnostics Of Contagious Diseases
Patrick Tabeling, Professor, ESPCI Paris Tech, France

A multiplexed system enabling, on a paper device, the simultaneous detection of several RNA strands is discussed.

Close of Conference